Results 161 to 170 of about 198,192 (354)

Risk Taking by Mutual Funds as a Response to Incentives

Journal of Political Economy, 1995
J. Chevalier, Glenn Ellison
semanticscholar   +1 more source

YAP1::TFE3 mediates endothelial‐to‐mesenchymal plasticity in epithelioid hemangioendothelioma

Molecular Oncology, EarlyView.
The YAP1::TFE3 fusion protein drives endothelial‐to‐mesenchymal transition (EndMT) plasticity, resulting in the loss of endothelial characteristics and gain of mesenchymal‐like properties, including resistance to anoikis, increased migratory capacity, and loss of contact growth inhibition in endothelial cells.
Ant Murphy, Samuel Hartzler, Paula A. Vargas Carranza, Shyaman Jayasundara, Madison E. Yates, Nimod D. Janson, Bozhi Liu, Annaleigh Benton, Majid Kazemian, Jason A. Hanna   +9 more
wiley   +1 more source

Stakeholders' perspectives on funding malaria, HIV/AIDS and tuberculosis services in Tanzania through domestic resources mobilisation: a qualitative study. [PDF]

BMJ Public Health
Ngadaya FD, Isangula K, Kimambo H, Soka G, Kitinya C, Philbert D, Mwenda L, Kagaruki GB, Kimaro G, Ngadaya E, Kahwa A, Mfinanga S.   +11 more
europepmc   +1 more source

The Engines of Privatization: Investment Funds and Fund Legislation in Privatizing Economies

, 1994
Matthew J. Hagopian
openalex   +1 more source

Do Active Managers of Retail Mutual Funds Have an Incentive to Closet Index in Down Markets? Fund Performance and Subsequent Annual Fund Flows, 1997-2011 [PDF]

, 2013
Aron Gottesman, Matthew R. Morey, Menahem Rosenberg   +2 more
openalex  

Emerging role of ARHGAP29 in melanoma cell phenotype switching

Molecular Oncology, EarlyView.
This study gives first insights into the role of ARHGAP29 in malignant melanoma. ARHGAP29 was revealed to be connected to tumor cell plasticity, promoting a mesenchymal‐like, invasive phenotype and driving tumor progression. Further, it modulates cell spreading by influencing RhoA/ROCK signaling and affects SMAD2 activity. Rho GTPase‐activating protein
Beatrice Charlotte Tröster, Melanie Kappelmann‐Fenzl, Anja Katrin Bosserhoff, Nicole Rachinger   +3 more
wiley   +1 more source

When the Money Stops: A Safety-First Plan for Paused Clinical Trials. [PDF]

Clin Transl Sci
Smith D.
europepmc   +1 more source

Evolution of Fund Selection, Sanctioning and Monitoring Process under the Fund of Funds Operations

, 2019
Mohammad Mustafa
openalex   +1 more source

Integration process: EU funding framework and the european structural and investment funds

, 2021
Αναστάσιος Μπαλής
openalex   +1 more source

Gut microbiota diversity is prognostic in metastatic hormone receptor‐positive breast cancer patients receiving chemotherapy and immunotherapy

Molecular Oncology, EarlyView.
In this exploratory study, we investigated the relationship between the gut microbiota and outcome in patients with metastatic hormone receptor‐positive breast cancer, treated in a randomized clinical trial with chemotherapy alone or chemotherapy in combination with immune checkpoint blockade.
Andreas Ullern, Kristian Holm, Nikolai Kragøe Andresen, Andreas Hagen Røssevold, Corinna Bang, Bjørn Naume, Johannes R. Hov, Jon Amund Kyte   +7 more
wiley   +1 more source